# The Effect of Allopurinol on Insulin Resistance and Blood Pressure

> **NCT00639756** · PHASE2 · COMPLETED · sponsor: **Hospital Mateo Orfila** · enrollment: 60 (estimated)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Allopurinol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00639756
- **Lead sponsor:** Hospital Mateo Orfila
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639756, "The Effect of Allopurinol on Insulin Resistance and Blood Pressure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00639756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*